Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/16/22
End: 01/19/23
Due: 01/19/24
Phase: N/A
Priority: Normal
Start: 11/21/19
End: 02/17/20
Due: 02/17/21
Phase: N/A
Priority: Normal
Start: 03/05/14
End: 11/03/16
Due: 11/03/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) | NCT04934670 | Xenikos | user2@example.com | None | 2022-06-16 | 2023-01-19 | 2024-01-19 | - | - | 2025-07-14 |
| T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802) | NCT04128319 | Xenikos | user2@example.com | None | 2019-11-21 | 2020-02-17 | 2021-02-17 | - | - | 2025-07-14 |
| Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD | NCT02027805 | Xenikos | user2@example.com | None | 2014-03-05 | 2016-11-03 | 2017-11-03 | - | - | 2025-07-14 |